Belgium· BE-AMP-SAM444376-00
Procysbi 25 mg
A mercaptamine product containing mercaptamine bitartrate, registered in Belgium by Chiesi Farmaceutici. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Mercaptamine · ATC A16AA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mercaptamine costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mercaptamine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$589.95
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mercaptamine Bitartrate
- Manufacturer
- Chiesi Farmaceutici
- Country
- Belgium (BE)
- ATC code
- A16AA04
- ATC class
- Mercaptamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7726748
- be_apb3878345
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaPROCYSBIAMGEN CANADA INC
- SpainPROCYSBI 25 MG CAPSULAS DURAS GASTRORRESISTENTESChiesi Farmaceutici S.P.A.
- FinlandPROCYSBIChiesi Farmaceutici S.p.A.
- FrancePROCYSBI 25 mg, gélule gastro-résistanteCHIESI FARMACEUTICI
- United KingdomProcysbi 25mg gastro-resistant capsulesChiesi Ltd
- IrelandPROCYSBI 25 mg gastro-resistant hard capsulesChiesi Farmaceutici S.p.A.
- IcelandProcysbiChiesi Farmaceutici S.p.A.*
- NorwayProcysbiChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/201e0265-9b64-41b9-b9d0-c7214efd236d GET /v1/drugs/201e0265-9b64-41b9-b9d0-c7214efd236d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gastro-resistant capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Procysbi 25 mg",
"name_fr": "Procysbi 25 mg",
"name_nl": "Procysbi 25 mg",
"amp_code": "SAM444376-00",
"strengths": [
"25.0000"
],
"pack_count": 1,
"substances": [
"Mercaptamine Bitartrate",
"Mercaptamine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Mercaptamine",
"authorisation_numbers": [
"EU/1/13/861/001"
]
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.